In vitro-generated respiratory mucosa: A new tool to study inhalational anthrax

Biochemical and Biophysical Research Communications

Volumn 305, Issue 3, 2003, Pages 624-632

  Radyuk, Svetlana N ^a,b   Mericko, Patricia A ^a   Popova, Taissia G ^a   Grene, Edith ^a   Alibek, Ken ^a,b  

^a Analex   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

3 D model; Airways; Anthrax; Infection; Inhalational

Indexed keywords

CELL SURFACE MARKER;

ANTHRAX; ARTICLE; BACTERIAL SPORE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROTECTION; COCULTURE; CONTROLLED STUDY; EVALUATION; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG GAS EXCHANGE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA;

ANTHRAX;

EID: 0038239847     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00830-1     Document Type: Article

References (32)

1. Friedlander A.M. Clinical aspects, diagnosis and treatment of anthrax. J. Appl. Microbiol. 87:1999;303.
2. Dixon T.C., Meselson M., Guillemin J., Hanna P.C. Anthrax. N. Engl. J. Med. 341:1999;815-826.
3. Inglesby T.V., O'Toole T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Friedlander A.M., Gerberding J., Hauer J., Hughes J., McDade J., Osterholm M.T., Parker G., Perl T.M., Russell P.K., Tonat K. Working Group on Civilian Biodefense, Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 281:1999;1735-1745.
4. Fritz D.L., Jaax N.K., Lawrence W.B., Davis K.J., Pitt M.L., Ezzell J.W., Friedlander A.M. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73:1995;691-702.
5. Grinberg L.M., Abramova F.A., Yampolskaya O.V., Walker D.H., Smith J.H. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 14:2001;482-495.
6. Albrink W.S. Pathogenesis of inhalational anthrax. Bacteriol. Rev. 25:1961;268-273.
7. Ross J.M. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 78:1957;485-494.
8. Guidi-Rontani C., Weber-Levy M., Labruyere E., Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31:1999;9-17.
9. Popov S.G., Villasmil R., Bernardi J., Grene E., Cardwell J., Popova T., Wu A., Alibek D., Bailey C., Alibek K. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527:2002;211-215.
10. Radyuk S.N., Sohal R.S., Orr W.C. Thioredoxin peroxidases can foster cytoprotection or cell death in response to different stressors - a study of thioredoxin peroxidase under- and over-expression in Drosophila cells. Biochem. J. 30:2003;. Pt [epub ahead of print].
11. Lehrer R.I., Rosenman M., Harwig S.S., Jackson R., Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods. 137:1991;167-173.
12. Kalina M., Riklis S. Alveolar type II-like cell colonies: effect of alveolar macrophages and macrophage-conditioned media. Cell Differ. 233:1988;231-236.
13. Takizawa H., Tanaka M., Takami K., Ohtoshi T., Ito K., Satoh M., Okada Y., Yamasawa F., Umeda A. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:2000;L906-L913.
14. Castillon N., Hinnrasky J., Zahm J.M., Kaplan H., Bonnet N., Corlieu P., Klossek J.M., Taouil K., Avril-Delplanque A., Peault B., Puchelle E. Polarized expression of cystic fibrosis transmembrane conductance regulator and associated epithelial proteins during the regeneration of human airway surface epithelium in three-dimensional culture. Lab Invest. 82:2002;989-998.
15. Tormey V.J., Faul J., Leonard C., Burke C.M., Dilmec A., Poulter L.W. T-cell cytokines may control the balance of functionally distinct macrophage populations. Immunology. 90:1997;463-469.
16. Popov S.G., Villasmil R., Bernardi J., Grene E., Cardwell J., Wu A., Alibek D., Bailey C., Alibek K. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:2002;349-355.
17. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:2001;5707-5713.
18. Mathia N.R., Timoszyk J., Stetsko P.I., Megill J.R., Smith R.L., Wall D.A. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J. Drug Target. 10:2002;31-40.
19. Birkness K.A., Deslauriers M., Bartlett J.H., White E.H., King C.H., Quinn F.D. An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection. Infect. Immun. 67:1999;653-658.
20. Adler K.B., Cheng P.W., Kim K.C. Characterization of guinea pig tracheal epithelial cells maintained in biphasic organotypic culture: cellular composition and biochemical analysis of released glycoconjugates. Am. J. Respir. Cell. Mol. Biol. 2:1990;145-154.
21. Beauregard K.E., Wimer-Mackin S., Collier R.J., Lencer W.I. Anthrax toxin entry into polarized epithelial cells. Infect. Immun. 67:1999;3026-3030.
22. Ehrhardt C., Fiegel J., Fuchs S., Abu-Dahab R., Schaefer U.F., Hanes J., Lehr C.M. Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. J. Aerosol. Med. 15:2002;131-139.
23. White M.K., Strayer D.S. Survival signaling in type II pneumocytes activated by surfactant protein A. Exp. Cell Res. 280:2002;270-279.
24. Beers M.F., Lomax C.A., Russo S.J. Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis. J. Biol. Chem. 273:1998;15287-15293.
25. Kjellstrom C., Ichimura K., Chen X.J., Riise G.C., Collins V.P. The origin of alveolar macrophages in the transplanted lung: a longitudinal microsatellite-based study of donor and recipient DNA. Transplantation. 69:2000;1984-1986.
26. Striz I., Slavcev A., Kalanin J., Jaresova M., Rennard S.I. Cell-cell contacts with epithelial cells modulate the phenotype of human macrophages. Inflammation. 254:2001;241-246.
27. Van den Heuvel M.M., Tensen C.P., van As J.H., Van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A., Sorg C., Hogger P., Beelen R.H. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J. Leukoc. Biol. 66:1999;858-866.
28. Pechkovsky D.V., Zissel G., Ziegenhagen M.W., Einhaus M., Taube C., Rabe K.F., Magnussen H., Papadopoulos T., Schlaak M., Muller-Quernheim J. Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. Eur. Cytokine Netw. 11:2000;618-625.
29. Domachowske J.B., Bonville C.A., Rosenberg H.F. Gene expression in epithelial cells in response to pneumovirus infection. Respir. Res. 2:2001;225-233.
30. Hiemstra P.S. Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr. Respir. Rev. 2:2001;306-310.
31. Goodrum K.J., Poulson-Dunlap J. Cytokine responses to group B streptococci induce nitric oxide production in respiratory epithelial cells. Infect. Immun. 70:2002;49-54.
32. Diamond G., Legarda D., Ryan L.K. The innate immune response of the respiratory epithelium. Immunol. Rev. 173:2000;27-38.